Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$3.25 - $5.27 $3,588 - $5,818
-1,104 Reduced 0.85%
128,539 $582,000
Q4 2023

Feb 13, 2024

BUY
$3.34 - $4.29 $4,903 - $6,297
1,468 Added 1.15%
129,643 $471,000
Q3 2023

Nov 13, 2023

BUY
$3.91 - $5.45 $17,821 - $24,841
4,558 Added 3.69%
128,175 $529,000
Q2 2023

Aug 04, 2023

BUY
$3.72 - $4.79 $2,819 - $3,630
758 Added 0.62%
123,617 $503,000
Q1 2023

May 12, 2023

BUY
$3.95 - $5.63 $9,657 - $13,765
2,445 Added 2.03%
122,859 $503,000
Q4 2022

Feb 10, 2023

BUY
$3.02 - $5.37 $6,801 - $12,093
2,252 Added 1.91%
120,414 $634,000
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $4,990 - $7,260
1,669 Added 1.43%
118,162 $365,000
Q2 2022

Aug 12, 2022

SELL
$2.67 - $4.77 $16,278 - $29,082
-6,097 Reduced 4.97%
116,493 $444,000
Q1 2022

May 13, 2022

SELL
$2.62 - $4.45 $22,607 - $38,399
-8,629 Reduced 6.58%
122,590 $451,000
Q4 2021

Feb 11, 2022

SELL
$4.05 - $5.37 $15,900 - $21,082
-3,926 Reduced 2.91%
131,219 $573,000
Q3 2021

Nov 12, 2021

SELL
$3.89 - $5.48 $12,494 - $17,601
-3,212 Reduced 2.32%
135,145 $588,000
Q2 2021

Aug 13, 2021

BUY
$3.61 - $5.45 $22,836 - $34,476
6,326 Added 4.79%
138,357 $754,000
Q1 2021

May 07, 2021

BUY
$3.14 - $6.14 $6,474 - $12,660
2,062 Added 1.59%
132,031 $518,000
Q4 2020

Feb 12, 2021

SELL
$1.79 - $4.04 $3,148 - $7,106
-1,759 Reduced 1.34%
129,969 $407,000
Q3 2020

Nov 04, 2020

BUY
$1.56 - $2.08 $2,432 - $3,242
1,559 Added 1.2%
131,728 $248,000
Q2 2020

Aug 12, 2020

BUY
$0.94 - $2.21 $18,019 - $42,365
19,170 Added 17.27%
130,169 $228,000
Q1 2020

May 04, 2020

SELL
$0.84 - $1.76 $5,387 - $11,288
-6,414 Reduced 5.46%
110,999 $114,000
Q4 2019

Feb 05, 2020

SELL
$1.14 - $1.49 $1,127 - $1,473
-989 Reduced 0.84%
117,413 $151,000
Q3 2019

Nov 08, 2019

SELL
$1.04 - $1.44 $855 - $1,185
-823 Reduced 0.69%
118,402 $148,000
Q2 2019

Aug 13, 2019

BUY
$1.09 - $1.88 $16,388 - $28,265
15,035 Added 14.43%
119,225 $137,000
Q1 2019

May 06, 2019

BUY
$1.14 - $2.25 $13,649 - $26,939
11,973 Added 12.98%
104,190 $205,000
Q4 2018

Feb 13, 2019

SELL
$1.02 - $2.05 $724 - $1,455
-710 Reduced 0.76%
92,217 $98,000
Q3 2018

Nov 09, 2018

BUY
$1.01 - $2.19 $1,692 - $3,670
1,676 Added 1.84%
92,927 $170,000
Q2 2018

Aug 08, 2018

BUY
$1.59 - $2.38 $145,089 - $217,177
91,251 New
91,251 $173,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.